AXGN AXOGEN
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 16 analyst firms say about AXOGEN: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 6 months
Analyst view · last 6M
14 rated views · 16 analyst/firm records · 16 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8077
- Russell 2000 · Safest consensus · 6MGood · #8 in the index88
Recent analyst activity · last 90 days
Our tracked history has 22 reports on AXGN from 13 analyst firms in the last 90 days (16 firms in the past year).
Comparing each firm's latest target with its previous one: 8 raised their price target, 2 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays raised its target from $50.00 (set 23 Oct 2026) to $60.00 on 29 Oct 2026.
Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Travis Steed | Buy | 12 Oct 2026 | 52.00 USD |
| Barclays | Christopher Pasquale | Buy | 29 Oct 2026 | 60.00 USD |
| Canaccord Genuity | Caitlin Roberts | Buy | 29 Oct 2026 | 60.00 USD |
| Citigroup | Unnamed analyst | Buy | 30 Jul 2026 | — |
| Citizens JMP | David Turkaly | Buy | 30 Jul 2026 | 55.00 USD |
| H.C. Wainwright | Yi Chen | Buy | 29 Oct 2026 | 56.00 USD |
| Jefferies | Michael A Sarcone | Buy | 28 Oct 2026 | 60.00 USD |
| Lake Street Capital Markets | Frank Takkinen | Buy | 5 Oct 2026 | Conflicting reports · excluded |
| Leerink Partners | Mike Kratky | Buy | 29 Oct 2026 | 56.00 USD |
| Mizuho | Anthony Petrone | ConflictConflicting reports · excluded | 28 Oct 2026 | 65.00 USD |
| Morgan Stanley | Unnamed analyst | Hold | 29 Sep 2026 | — |
| Raymond James | Jayson Bedford | Buy | 29 Oct 2026 | 57.00 USD |
| Truist | Ravi Misra | Buy | 29 Oct 2026 | 60.00 USD |
| Weiss Ratings | Unnamed analyst | — | 26 Aug 2026 | — |
| Wells Fargo | Larry Biegelsen | Buy | 29 Oct 2026 | 56.00 USD |
| Data feed RESEARCH | Research Team | Hold | 29 May 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:51 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.